Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
As of today, Moderna(MRNA) shares are valued at $225.47. The company's market cap stands at 89.82B, with a P/E ratio of -28.18.
As of 2026-10-11, Moderna(MRNA) stock has fluctuated between $195.88 and $225.52. The current price stands at $225.47, placing the stock +15.1% above today's low and -0.0% off the high.
The Moderna(MRNA)'s current trading volume is 28.95M, compared to an average daily volume of 19.21M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $225.52 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $225.52 at its peak.
MRNA News
has delivered a very strong run over the past year, which now puts the focus squarely on whether the current share price is properly supported by its sales base...
Moderna (MRNA +14.21%) has been one of the market's hottest stocks this year, surging more than 500% so far. The biotech stock has delivered these kinds of gain...
Strong clinical and regulatory progress has driven Moderna's (MRNA +14.21%) shares significantly higher this year. The biotech has gained over 560%, while the S...
Analyst ratings
56%
of 27 ratingsMore MRNA News
Moderna Inc (NASDAQ:MRNA) shares are rising Friday to a fresh 52-week high. The stock enters the Nasdaq-100 Index. Here’s what you should know. Moderna stock i...
Investing Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies Vaccine and biotechnology names are leading a sharp sector rally, and a smal...
Investing Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock trades at $207.80,...
BofA raised the firm’s price target on Moderna (MRNA) to $200 from $170 and keeps a Neutral rating on the shares as part of a Q3 earnings preview for the biotec...
Moderna appointed former executive Juan Andres as Chief Operating Officer in early October 2026, tasking him with overseeing global manufacturing and operationa...
Choosing between Axsome Therapeutics (AXSM -0.79%) and Moderna (MRNA +4.81%) requires weighing a focused neuroscience portfolio against a broad, potentially rev...
The S&P 500 (SPX) finished with a 0.22% loss on Wednesday as tech stocks sold off and Treasury yields remained elevated. Healthcare led all sectors with a 1.06%...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.